Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Malek

Showing results (211-220 of 225) with videos related to

Pageof 23
Sort By:
Diabetes|August 27, 2020
Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple MechanismsNatasha C Ward, Jen Bon Lui, Rosmely Hernandez, et al.
Journal of Bacteriology|February 1, 1994
Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic ratsR Malek, J G Fisher, A Caleca, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|March 24, 2012
Endovascular mechanical thrombectomy for the treatment of acute ischemic stroke due to arterial dissectionJ D Fields, H L Lutsep, M R Rymer, et al.
Cell Death and Differentiation|December 3, 2016
Transient mitochondrial DNA double strand breaks in mice cause accelerated aging phenotypes in a ROS-dependent but p53/p21-independent mannerMilena Pinto, Alicia M Pickrell, Xiao Wang, et al.
JCI Insight|August 7, 2025
BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHDYing Ding, Aixin Yu, Milos Vujanac, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998
IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejectionX C Li, P Roy-Chaudhury, W W Hancock, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2018
IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T CellsNatasha C Ward, Aixin Yu, Alejandro Moro, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2024
Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TMEJuliano Tiburcio de Freitas, Varsha Thakur, Kathryn M LaPorte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2021
Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus ErythematosusJenny H Xie, Yifan Zhang, Martine Loubeau, et al.
Journal of Autoimmunity|January 31, 2015
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patientsMichelle Rosenzwajg, Guillaume Churlaud, Roberto Mallone, et al.
Pageof 23

Showing results (211-220 of 225) with videos related to

Sort By:
Pageof 23
Diabetes|August 27, 2020
Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple MechanismsNatasha C Ward, Jen Bon Lui, Rosmely Hernandez, et al.
Journal of Bacteriology|February 1, 1994
Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic ratsR Malek, J G Fisher, A Caleca, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|March 24, 2012
Endovascular mechanical thrombectomy for the treatment of acute ischemic stroke due to arterial dissectionJ D Fields, H L Lutsep, M R Rymer, et al.
Cell Death and Differentiation|December 3, 2016
Transient mitochondrial DNA double strand breaks in mice cause accelerated aging phenotypes in a ROS-dependent but p53/p21-independent mannerMilena Pinto, Alicia M Pickrell, Xiao Wang, et al.
JCI Insight|August 7, 2025
BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHDYing Ding, Aixin Yu, Milos Vujanac, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998
IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejectionX C Li, P Roy-Chaudhury, W W Hancock, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2018
IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T CellsNatasha C Ward, Aixin Yu, Alejandro Moro, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2024
Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TMEJuliano Tiburcio de Freitas, Varsha Thakur, Kathryn M LaPorte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2021
Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus ErythematosusJenny H Xie, Yifan Zhang, Martine Loubeau, et al.
Journal of Autoimmunity|January 31, 2015
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patientsMichelle Rosenzwajg, Guillaume Churlaud, Roberto Mallone, et al.
Pageof 23